Mutually adjusted metaregression coefficients demonstrated significantly more favorable OS in patients with PD-L1 highly expressed on immune vs tumor cells (regression coefficient, −1.15; 95% CI, −1.95 to −0.35; P = .005). Here, CD274 is linked to neoplasm.